Research Article
The Impact of Experience with a Family Member with Alzheimer’s Disease on Views about the Disease across Five Countries
Table 4
Attitudes about government spending on Alzheimer’s research and care, by experience with a family member.
| | Attitude about spending Country (unweighted for total sample; those who have had a family member with AD; those who have not) | Total
% (CI 95%) | Yes, have ever had family member with AD
% (CI 95%) | No, have not
% (CI 95%) | value (family member versus no family member) |
| | Favor increased government spending on research on new treatments for Alzheimer’s disease | | | | | | France (; 166; 363) | 83 (79–86) | 84 (78–91) | 82 (77–86) | 0.497 | | Germany (; 177; 317) | 68 (63–73) | 75 (68–83) | 65 (59–71) | 0.032 | | Poland (; 92; 410) | 75 (70–79) | 85 (76–94) | 72 (67–77) | 0.013 | | Spain (; 172; 328) | 83 (79–87) | 87 (81–93) | 82 (77–86) | 0.212 | | US (; 257; 379) | 67 (63–71) | 66 (60–73) | 68 (62–73) | 0.758 | | Favor increased government spending on caring for people with Alzheimer’s disease | | | | | | France (; 166; 363) | 85 (81–88) | 83 (77–90) | 85 (81–89) | 0.599 | | Germany (; 177; 317) | 69 (64–73) | 73 (65–81) | 67 (61–73) | 0.288 | | Poland (; 92; 410) | 71 (67–76) | 86 (77–94) | 68 (63–73) | 0.006 | | Spain (; 172; 328) | 79 (75–83) | 82 (76–89) | 77 (71–82) | 0.187 | | US (; 257; 379) | 60 (56–64) | 64 (57–70) | 57 (51–63) | 0.129 |
|
|
Source: [13].
|
